Performance and Safety of Praziquantel for Treatment of Intestinal Schistosomiasis in Infants and Preschool Children

BACKGROUND: In 2012 the WHO formally recognised that infants and preschool children are at significant risk of schistosomiasis and qualify for treatment with praziquantel (PZQ). Targeted surveys determining both the performance and safety of this drug are now needed in endemic areas. We have formall...

Descripción completa

Detalles Bibliográficos
Autores principales: Sousa-Figueiredo, José C., Betson, Martha, Atuhaire, Aaron, Arinaitwe, Moses, Navaratnam, Annalan M. D., Kabatereine, Narcis B., Bickle, Quentin, Stothard, J. Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475660/
https://www.ncbi.nlm.nih.gov/pubmed/23094120
http://dx.doi.org/10.1371/journal.pntd.0001864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475660/
https://www.ncbi.nlm.nih.gov/pubmed/23094120
http://dx.doi.org/10.1371/journal.pntd.0001864

Ejemplares similares